Home
/
Grants and Training
/
< Back To Funding Opportunities and Contacts
/
All Funding Opportunities

All Funding Opportunities

Active notices and funding available from the NHLBI.

Filter by keyword

ADD OTHER FILTERS

Show:

Showing 10 out of 4337 results

PA-24-193

| Released

April 24, 2024

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)

Expires

May 08, 2027

PA-24-191

| Released

April 23, 2024

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)

Expires

May 08, 2027

PA-24-190

| Released

April 23, 2024

Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)

Expires

May 08, 2027

PAR-24-110

| Released

April 19, 2024

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)

Expires

September 08, 2027

NOT-HL-24-013

| Released

April 15, 2024

Notice of NHLBI Participation in NOT-OD-24-078 "Notice of Special Interest (NOSI): Supporting the Exploration of Cloud in NIH-supported Research"

Expires

January 01, 2027

NOT-HL-24-011

| Released

April 15, 2024

Notice of Renewal / Resubmission / Revision Application Due Date Correction to PAR-24-172 "NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)"

Expires

January 01, 2027

NOT-HL-24-012

| Released

April 11, 2024

Notice of NHLBI Participation in NOT-AI-24-007 "Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)"

Expires

January 01, 2027

PA-24-185

| Released

April 09, 2024

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)

Expires

May 08, 2027

PA-24-184

| Released

April 09, 2024

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)

Expires

May 08, 2027

RFA-AI-24-013

| Released

April 08, 2024

Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)

Expires

July 31, 2024